Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Johannes H. Schulte, Falk Hertwig et al.|Nature|2015Cited by 608
Comparison of RNA-seq and microarray-based models for clinical endpoint predictionWenqian Zhang, Carolina Rosswog, Danielle Thierry‐Mieg et al.|Genome Biology|2015Cited by 429
Vitamin B6 in Primary Hyperoxaluria IHeike Hoyer‐Kuhn, Bernd Höppe, Sina Kohbrok et al.|Clinical Journal of the American Society of Nephrology|2014Cited by 136
Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Clinical Cancer Research|2014Cited by 99
Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0